Showing 35,141 results

Filters
Injectable & long-acting HIV treatment

Are Cabotegravir Injections More Tolerable Than Lenacapavir?

Editor's pick
POZ
21 October 2025
Global health initiatives

With Future of UNAIDS in Question, Top Official Says ‘Very Difficult’ to Envision 2026 Shutdown

Editor's pick
Health Policy Watch
21 October 2025
Global health initiatives

UNAids is set to close in 2026 – four years early. Are experts right to be alarmed?

Editor's pick
The Guardian
21 October 2025
Quality of life

People with HIV report little difference in quality of life compared with matched controls, but more depression

News
20 October 2025
Global health initiatives

Global Health Leaders Urge Fewer Agencies Amid Funding Crisis

Editor's pick
Health Policy Watch
17 October 2025
Global health initiatives

South Africa: PEPFAR cuts leave clinics short of staff

Editor's pick
GroundUp News
17 October 2025
Starting treatment

Twice-Yearly Lenacapavir Could Be an Option for Initial HIV Treatment

Editor's pick
POZ
17 October 2025
PrEP programmes & uptake

HIV rates are highest in the American South, despite effective treatments – a clash between culture and public health

Editor's pick
The Conversation
17 October 2025
Finance & funding

US aid cuts severely undermine Senegal’s fight against HIV

Editor's pick
El País
17 October 2025
PrEP policies & guidelines

NICE approves annual access to injectable cabotegravir PrEP in England for 1000 people

Editor's pick
i-Base
17 October 2025
PrEP policies & guidelines

NHS to roll out first long-acting injection to prevent HIV

Editor's pick
NHS England
17 October 2025
Global health initiatives

UNAIDS faces uncertain future amid UN reform push

Editor's pick
Devex (requires free registration)
14 October 2025
Health services & systems

South Africa: Pharmacists can treat people with HIV, appeal court rules

Editor's pick
GroundUp News
14 October 2025
Government, leadership & policy

US aid cuts: a new era of HIV care in Malawi

Editor's pick
The Lancet (requires free registration)
13 October 2025
Pharmaceutical industry

Gilead inks trio of Biktarvy patent settlements, waylaying US copycats until 2036

Editor's pick
FiercePharma
9 October 2025
Pregnancy and vertical transmission

Prenatal Rilpivirine May Be Safe in HIV-Positive Pregnancies

Editor's pick
Medscape (requires free registration)
9 October 2025
Government, leadership & policy

HIV, STI Leaders Condemn the Recent Deletion of Critical Public Health Information From CDC Websites

Editor's pick
POZ
9 October 2025
People who inject drugs

‘Bluetoothing’: Blood-Sharing Drug Trend Fuels Alarming Global H.I.V. Surge

Editor's pick
The New York Times
9 October 2025
Ageing & HIV

Screening for Frailty in People With HIV: Practical Approaches for Providers

Editor's pick
TheBodyPro
9 October 2025
Treatment guidelines

US HIV Guidelines Add Chapter on Cardiovascular and Metabolic Health

Editor's pick
POZ
9 October 2025
Injectable & long-acting PrEP

The six-monthly anti-HIV jab is coming. But can South Africa keep track of millions of users?

Editor's pick
Bhekisisa
9 October 2025
Starting treatment

Early HIV Treatment Shows Mixed Effects on Heart Health

Editor's pick
Medscape (requires free registration)
9 October 2025
Cardiovascular disease

Which CVD Risk Calculator Is Best in HIV Care? Global Assessment Leaves More Questions Than Answers

Editor's pick
TheBodyPro
7 October 2025
The search for a cure

HIV and the Gut: Why It Matters for a Cure

Editor's pick
HIV Cure
7 October 2025